Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pillar5 Pharma Inc.
FDA Inspection
•Pillar5 Pharma Inc.•February 7, 2025

Pillar5 Pharma Inc. – FDA Inspection, Feb 7, 2025

Record Details

This FDA Inspection record concerns Pillar5 Pharma Inc., with an inspection on February 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Pillar5 Pharma Inc.
Inspection Date
February 7, 2025
Product Type
Human Drugs
Office
Office of Inspections and Investigations
People
  • Miguel A. Martinez
  • Patty P. Kaewussdangkul (FDA Associated Person)
View Company Profile

ID · 9bde498e-2566-4025-8c5b-53bacfb5ac30

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1261773
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

9
  1. 21 CFR 211.113(b)Validation lacking for sterile drug products
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.166(a)Written program not followed
  4. 21 CFR 211.170(b)Annual visual exams of drug products
  5. 21 CFR 211.170(b)Drug product reserve containers
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.192Written record of investigation incomplete
  8. 21 CFR 211.194(d)Laboratory equipment calibration records
  9. 21 CFR 211.42(c)(10)(v)Cleaning System

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pillar5 Pharma Inc.

9
DateClassificationOfficeProject area
June 5, 2026Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
December 15, 2023OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 21, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 17, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 26, 2018VAICenter for Veterinary MedicinePre-Approval Eval. of Animal Drugs and Food Additives
View all 9 other inspections on the company page
Other documents for Pillar5 Pharma Inc.
  • FDA Inspection 1323174 - 2026-06-05
  • FDA Inspection 1226692 - 2023-12-15
  • FDA Inspection 1119040 - 2020-02-21
  • FDA Inspection 1058599 - 2018-05-17
  • FDA Inspection 1038745 - 2018-01-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pillar5 Pharma Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.